Index > Factsheets > Coluracetam


SummaryA nootropic drug of the racetam class, originally developed to treat Alzheimer's disease, it is currently being investigated as a treatment for major depressive disorder and generalised anxiety disorder. May be a modulator of the AMPA receptor. Limited recreational value.
DoseOral Light: 3-5mg Common: 5-10mg Strong: 10-20mg+
Sublingual/Insufflated Light: 2-5mg Common: 5-10mg Strong: 10mg+
OnsetOral: 15-30 minutes.
Sublingual: 5-10 minutes.
Intranasal: 1-5 minutes
Duration3-6 hours depending on stomach contents/ROA/ect.
After-effects1-4 hours.